J Rheum Dis.
2014 Oct;21(5):274-277. 10.4078/jrd.2014.21.5.274.
A Case of Infliximab-induced Psoriasis in Treatment of Ankylosing Spondylitis
- Affiliations
-
- 1Division of Rheumatology, Department of Internal Medicine, Maryknoll Medical Center, Busan, Korea. ete@lycos.co.kr
- KMID: 2222954
- DOI: http://doi.org/10.4078/jrd.2014.21.5.274
Abstract
- Infliximab, which is indicated for refractory rheumatoid arthritis (RA), ankylosing spondylitis (AS) and Crohn's disease, has cutaneous adverse events including skin rash, urticaria, pruritus, and lupus-like eruption. Psoriasis induced by infliximab is very rare. In Korea, it is infrequently reported in Crohn's disease or RA and never reported in AS. We encountered a case of psoriasis induced by infliximab treatment for AS, and report here on this case along with a review of the relevant literature.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Development of Renal Disorder in a Patient Receiving Infliximab (Remicade(R)) for Psoriasis
- A Case of Hypopigmented Mycosis Fungoides in a Patient with Ankylosing Spondylitis during Treatment with Infliximab
- Occurrence of tuberculous pleurisy associated with infliximab therapy
- A Case of Tuberculous Peritonitis in a Patient with Ankylosing Spondylitis during Infliximab Therapy
- TNF Inhibitors and Uveitis in Ankylosing Spondylitis
